Research suggests that genetic sequencing technologies should be used to screen for mutated cells in stem cell cultures, so they can be excluded from scientific experiments and clinical therapies.
Researchers at the Institute for Aging Research, which operates within Hebrew Senior Life, the only senior health care and housing organization affiliated with Harvard Medical School, have studied how to prevent falls, a leading cause of preventable death among older adults.
Scientists studying stem cell and regenerative biology are probing the secrets of aging, examining both whether decline is inevitable and how to fight the diseases that multiply with time.
Harvard researchers have identified a compound that helps protect the cells destroyed by spinal muscular atrophy, the most frequent fatal genetic disease of young children.
For nearly 80 years, the Harvard Study of Adult Development has been producing data and lessons on how to live longer, happier, and healthier lives.
A study led by Harvard Medical School and Brigham and Women’s Hospital physician Reisa Sperling is investigating whether early intervention can be effective against Alzheimer’s disease, as it is against heart disease, cancer and other ailments.
The body’s ability to repair DNA damage declines with age, which causes gradual cell demise, overall bodily degeneration, and greater susceptibility to cancer. Experiments in mice suggest a way to thwart DNA damage.
Harvard Stem Cell Institute researchers have developed a drug cocktail that unlocks the potential to regrow inner-ear hair cells, which could help combat hearing loss.
Children ages 3 to 7 who don’t get enough sleep are more likely to have problems with attention, emotional control, and peer relationships in mid-childhood, according to a new study led by a Harvard pediatrician.
A rare anemia is opening scientists up to a new way of thinking about how to adapt and employ cytokines, messenger molecules of the blood and immune system, as tools for treatment and the promise of precision medicine.
Sign up for daily emails with the latest Harvard news.
Biologist Brian D. Farrell gave a lecture at the Harvard Museum of Natural History exploring the roots of consciousness.
Psychiatrist Jeff Huff is leading an MGH effort to determine whether positive thinking can promote better health.
Researchers saw improvement in carpal tunnel syndrome symptoms after “real” acupuncture and brain remapping. The study also found no physiologic improvements from “sham” acupuncture.
In December, Congress passed a bipartisan law to boost federal medical research spending and to ease the approval of new drugs. In a panel discussion, experts at the Harvard T.H. Chan School of Public Health talked about its pros and cons, including whether it will be funded, and whether the relaxed drug approval guidelines are too easy.
The “Harvard Chan: This Week in Health” podcast sits down with Aaron Bernstein, associate director of the Center for Health and the Global Environment at the Harvard Chan School, to discuss how climate change will impact health and health care costs.
Researchers find vitamin D helps the body fight acute respiratory infection.
At a Kennedy School panel on the future of health insurance, the analysts disagreed on many key points, but did agree that any new national plan, if there is one, will take time to create.
Ayelet Waldman stopped at Harvard Law School to talk about her new book, “A Really Good Day: How Microdosing Made a Mega Difference In My Mood, My Marriage, and My Life.”
A study by Harvard Medical School faculty members at Brigham and Women’s Hospital is exploring the health benefits of cocoa in a massive, 18,000-person study that may provide answers hinted at in smaller studies.
Harvard researchers were able, for the first time, to use patients’ own cells to create cells similar to those in bone marrow, and identify potential treatments for a rare blood disorder.
The Gazette speaks with the Medical School's Staci Gruber, who thinks that state marijuana legalization policy has run ahead of science.
A Harvard Chan School researcher has launched a website to connect citizens with data on the water coming through their taps.
Harvard Medical School scientists and colleagues from Massachusetts General Hospital have partly restored hearing in mice with a genetic form of deafness. The new approach overcomes a longstanding barrier to gene therapy for inherited and acquired deafness.
A new study out of Harvard-affiliated Dana-Farber/Boston Children’s Cancer and Blood Disorders Center suggests that precision medicine can provide vital care in treatment and diagnosis of pediatric brain tumors.
Science journalist Gary Taubes brought his “Case Against Sugar” to Harvard Law School.
Professor Jennifer Leaning, co-chair of a new committee set up to examine the health consequences of Syria’s civil war, talks about the country’s prospects for stability and recovery.
A new study by researchers at Beth Israel Deaconess Medical Center examines the neuroanatomy behind delusional misidentification syndromes.
Harvard researchers at Massachusetts General Hospital have found a topical chemotherapy and an immune-system-activating compound that is able to rapidly clear actinic keratosis lesions from patients participating in a clinical trial.
Boston has become a safer place for bicyclists as it has improved its infrastructure, a new study from the Harvard T.H. Chan School of Public Health says, with the chances of being injured in a bicycle accident falling 14 percent a year between 2009 and 2012.
A Harvard study has found that women who used ibuprofen or acetaminophen for six years or more were at higher risk of hearing loss than those who used these medications for a year or less.
Cancer patients have new weapons on their side, provided by targeted drug therapy and, more recently, immune therapy. Now, the recent discovery of large numbers of noncoding RNA that are active in disease provides a new opportunity to both understand and fight cancer, according to Pier Paolo Pandolfi, professor at Harvard Medical School and director of the Cancer Center and Cancer Research Institute at Beth Israel Deaconess Medical Center.
A new Harvard center on health and happiness had its academic coming-out party Friday, hosting a daylong symposium that highlighted what science does and doesn’t say about the interaction of health and happiness, and identifying pathways where investigators should probe next.
A panel sponsored by the Harvard Law School’s Food Law and Policy Clinic and the Union of Concerned Scientists brought food luminaries to talk about the need for a national food policy.
Harvard researchers have developed a hydrogel that can be easily injected into blood vessels, helping to stop uncontrolled bleeding even in patients on blood-thinners or with bleeding disorders.
Scientists and ethicists gathered at Harvard Law School to discuss the ethics of human embryo experimentation and whether a two-week developmental time limit on their use is appropriate any longer.
Despite decades of research aimed at understanding suicide, scientists are no better at predicting self-harm than they were a half-century ago.
New research highlights the skill and poise of doctors who tended to stranded crewmen in the famed Shackleton saga.
A new Harvard report addresses legal and ethical factors affecting the health of players in the National Football League, and makes recommendations to improve it.
A new study examines whether lifestyle changes can offset genetic risk of heart disease.
Researchers at Harvard’s Wyss Institute have developed an instrument that smokes cigarettes like a human, and delivers whole smoke to the air space of microfluidic human airway chips. The machine may enable new insights into how nonsmokers and COPD patients respond to smoke.
Restoring the cancer-killing zeal of T cells is being seen as one of the most successful new approaches to cancer treatment in nearly a decade, although researchers note it has shown effectiveness in only about a quarter of cases.
A new approach to manufacturing organs-on-chips developed by Harvard researchers could cut the length and cost of clinical trials significantly.
A Harvard Chan School study suggests that relaxing current U.S. guidelines could provide greater health benefits with less harm and for less money in women who are vaccinated against human papillomavirus.
Leaders from the scientific and business world gathered at Harvard Business School on Oct. 6 to examine regenerative medicine’s scientific and commercial promise.
According to Harvard sociologist Robert Sampson’s theory of “ecology of toxic inequality,” higher lead levels in the blood are often directly tied to racial and ethnic segregation.
By studying women ages 45 to 55, investigators at Harvard-affiliated Brigham and Women’s Hospital have found that reproductive stage, not simply chronological age, may contribute to changes in memory and brain function.
Programs to combat obesity may be aggravating eating disorders and undermining their severity, said experts during a panel discussion hosted by Harvard T.H. Chan School of Public Health.
Chronic myelogenous leukemia (CML) is a slowly progressing type of blood cancer that develops in the bone marrow. Researchers discovered that CML stem cells die in response to inhibition of a protein called Ezh2. Drugs that target the protein are currently being tested in clinical trials for other cancers.
A gene therapy trial points to a healthier future for a young patient suffering from a rare immune disease.
Researchers examined a group of older adults with extraordinary memory performance and found that certain key areas of their brains resembled those of young people.